- Home
- CDTX vs GLO Comparison
CDTX vs GLO Comparison
Compare CDTX & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- GLO
- Stock Information
- Founded
- CDTX 2012
- GLO 2006
- Country
- CDTX United States
- GLO United States
- Employees
- CDTX N/A
- GLO N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- GLO Finance/Investors Services
- Sector
- CDTX Health Care
- GLO Finance
- Exchange
- CDTX Nasdaq
- GLO Nasdaq
- Market Cap
- CDTX 242.5M
- GLO 232.4M
- IPO Year
- CDTX 2015
- GLO N/A
- Fundamental
- Price
- CDTX $20.53
- GLO $5.13
- Analyst Decision
- CDTX Strong Buy
- GLO
- Analyst Count
- CDTX 6
- GLO 0
- Target Price
- CDTX $32.20
- GLO N/A
- AVG Volume (30 Days)
- CDTX 86.5K
- GLO 170.5K
- Earning Date
- CDTX 11-07-2024
- GLO 01-01-0001
- Dividend Yield
- CDTX N/A
- GLO 11.38%
- EPS Growth
- CDTX N/A
- GLO N/A
- EPS
- CDTX N/A
- GLO N/A
- Revenue
- CDTX $44,653,000.00
- GLO N/A
- Revenue This Year
- CDTX N/A
- GLO N/A
- Revenue Next Year
- CDTX N/A
- GLO N/A
- P/E Ratio
- CDTX N/A
- GLO N/A
- Revenue Growth
- CDTX 44.48
- GLO N/A
- 52 Week Low
- CDTX $10.00
- GLO $4.08
- 52 Week High
- CDTX $24.99
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- CDTX 55.06
- GLO 32.10
- Support Level
- CDTX $21.15
- GLO $5.26
- Resistance Level
- CDTX $24.99
- GLO $5.33
- Average True Range (ATR)
- CDTX 2.10
- GLO 0.05
- MACD
- CDTX -0.15
- GLO -0.01
- Stochastic Oscillator
- CDTX 41.16
- GLO 0.00
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return. The fund invests in a mix of U.S. and non-U.S. equity and debt securities.